Report Detail
Global (United States, European Union and China) Cardiovascular Drugs Market Research Report 2019-2025
- RnM3618353 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is the official journal. The editors-in-chief are Willem J. Remme (Carol Davila University of Medicine and Pharmacy) and Robert S. Rosenson (Icahn School of Medicine at Mount Sinai).
Geographically, North America captured lion’s share of global cardiovascular drugs market in 2016. However increasing adoption of generics in the U.S. is key concern area among key players. Asia Pacific market is projected to gain market share during the forecast period and is likely to be key revenue generator in the coming years. Initiatives by local governments to attain self-sufficiency in manufacturing pharmaceuticals and incentives for generic production in countries such as Brazil, South Africa, Saudi Arabia, etc. is likely to boost market growth in Latin America and Middle East & Africa.
In 2019, the market size of Cardiovascular Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiovascular Drugs.
This report studies the global market size of Cardiovascular Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiovascular Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Amgen
AstraZeneca
Bayer
Bristol Myers Squibb and Pfizer
Daiichi Sankyo
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Portola
Sanofi
Market Segment by Product Type
Renin-Angiotensin System Blockers
Beta Blockers
Diuretics
Anti-Clotting Agents
Antihyperlipidemic
Market Segment by Application
Hypertension
Hyperlipidemia
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cardiovascular Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cardiovascular Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cardiovascular Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cardiovascular Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Renin-Angiotensin System Blockers
- 1.3.3 Beta Blockers
- 1.3.4 Diuretics
- 1.3.5 Anti-Clotting Agents
- 1.3.6 Antihyperlipidemic
- 1.4 Market Segment by Application
- 1.4.1 Global Cardiovascular Drugs Market Share by Application (2019-2025)
- 1.4.2 Hypertension
- 1.4.3 Hyperlipidemia
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cardiovascular Drugs Market Size
- 2.1.1 Global Cardiovascular Drugs Revenue 2014-2025
- 2.1.2 Global Cardiovascular Drugs Sales 2014-2025
- 2.2 Cardiovascular Drugs Growth Rate by Regions
- 2.2.1 Global Cardiovascular Drugs Sales by Regions 2014-2019
- 2.2.2 Global Cardiovascular Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cardiovascular Drugs Sales by Manufacturers
- 3.1.1 Cardiovascular Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Cardiovascular Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cardiovascular Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Cardiovascular Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cardiovascular Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Cardiovascular Drugs Price by Manufacturers
- 3.4 Key Manufacturers Cardiovascular Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cardiovascular Drugs Market
- 3.6 Key Manufacturers Cardiovascular Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Renin-Angiotensin System Blockers Sales and Revenue (2014-2019)
- 4.1.2 Beta Blockers Sales and Revenue (2014-2019)
- 4.1.3 Diuretics Sales and Revenue (2014-2019)
- 4.1.4 Anti-Clotting Agents Sales and Revenue (2014-2019)
- 4.1.5 Antihyperlipidemic Sales and Revenue (2014-2019)
- 4.2 Global Cardiovascular Drugs Sales Market Share by Type
- 4.3 Global Cardiovascular Drugs Revenue Market Share by Type
- 4.4 Cardiovascular Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cardiovascular Drugs Sales by Application
6 United States
- 6.1 United States Cardiovascular Drugs Breakdown Data by Company
- 6.2 United States Cardiovascular Drugs Breakdown Data by Type
- 6.3 United States Cardiovascular Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Cardiovascular Drugs Breakdown Data by Company
- 7.2 European Union Cardiovascular Drugs Breakdown Data by Type
- 7.3 European Union Cardiovascular Drugs Breakdown Data by Application
8 China
- 8.1 China Cardiovascular Drugs Breakdown Data by Company
- 8.2 China Cardiovascular Drugs Breakdown Data by Type
- 8.3 China Cardiovascular Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cardiovascular Drugs Breakdown Data by Company
- 9.2 Rest of World Cardiovascular Drugs Breakdown Data by Type
- 9.3 Rest of World Cardiovascular Drugs Breakdown Data by Application
- 9.4 Rest of World Cardiovascular Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Cardiovascular Drugs Sales by Countries
- 9.4.2 Rest of World Cardiovascular Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Amgen
- 10.1.1 Amgen Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.1.4 Cardiovascular Drugs Product Introduction
- 10.1.5 Amgen Recent Development
- 10.2 AstraZeneca
- 10.2.1 AstraZeneca Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.2.4 Cardiovascular Drugs Product Introduction
- 10.2.5 AstraZeneca Recent Development
- 10.3 Bayer
- 10.3.1 Bayer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.3.4 Cardiovascular Drugs Product Introduction
- 10.3.5 Bayer Recent Development
- 10.4 Bristol Myers Squibb and Pfizer
- 10.4.1 Bristol Myers Squibb and Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.4.4 Cardiovascular Drugs Product Introduction
- 10.4.5 Bristol Myers Squibb and Pfizer Recent Development
- 10.5 Daiichi Sankyo
- 10.5.1 Daiichi Sankyo Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.5.4 Cardiovascular Drugs Product Introduction
- 10.5.5 Daiichi Sankyo Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.6.4 Cardiovascular Drugs Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 Merck & Co.
- 10.7.1 Merck & Co. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.7.4 Cardiovascular Drugs Product Introduction
- 10.7.5 Merck & Co. Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.8.4 Cardiovascular Drugs Product Introduction
- 10.8.5 Novartis Recent Development
- 10.9 Pfizer
- 10.9.1 Pfizer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.9.4 Cardiovascular Drugs Product Introduction
- 10.9.5 Pfizer Recent Development
- 10.10 Portola
- 10.10.1 Portola Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cardiovascular Drugs
- 10.10.4 Cardiovascular Drugs Product Introduction
- 10.10.5 Portola Recent Development
- 10.11 Sanofi
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cardiovascular Drugs Sales Channels
- 11.2.2 Cardiovascular Drugs Distributors
- 11.3 Cardiovascular Drugs Customers
12 Market Forecast
- 12.1 Global Cardiovascular Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Cardiovascular Drugs Sales Forecast by Type
- 12.3 Global Cardiovascular Drugs Sales Forecast by Application
- 12.4 Cardiovascular Drugs Forecast by Regions
- 12.4.1 Global Cardiovascular Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cardiovascular Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cardiovascular Drugs . Industry analysis & Market Report on Cardiovascular Drugs is a syndicated market report, published as Global (United States, European Union and China) Cardiovascular Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cardiovascular Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
